ChatGPT Health adds Epic integration for clinicians to import patient data — SkimNews
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- OpenAI integrated ChatGPT Health with Epic's EHR system, which holds data for over 325 million patients, allowing clinicians to import patient data and ask AI questions; in some deployments ChatGPT is embedded directly within EHR workflows.
- ChatGPT Health features give clinicians read-only access to appointment notes, laboratory results, medications, and specialist documentation for summarization, history review, and pre-visit prep — with no AI write-back to records.
- OpenAI launched a new Healthcare Public Data plugin pulling from ClinicalTrials.gov, CMS Coverage, RxNorm, DailyMed, and PubMed to help with trial eligibility criteria, medication identifiers, and coverage policy versions.
- OpenAI is now letting organizations with a Business Associate Agreement use ChatGPT Work, Codex, apps, and connectors for compliant healthcare workflows.
- ChatGPT received over 300 million health-related queries per week as of last month when OpenAI rolled out ChatGPT for health to all U.S. consumers, even as the company maintains AI is not suitable for diagnosis or treatment.
- OpenAI's internal safety evaluation found 99.1% of 4,300 physician responses across 27 clinical use cases were safe, though the company acknowledged that even a few unsafe answers can cause harmful results.
- OpenAI faces two active lawsuits: a Florida pastor alleging ChatGPT gave him a near-fatal recommendation, and a May suit from family members blaming ChatGPT for wrongful dosage advice — claims that sit directly beside the company's 99.1% safety figure.
Why it matters: OpenAI gains clinician-level access to a 325-million-patient EHR network while two active lawsuits allege ChatGPT's health advice caused serious harm — the read-only design caps some risk, but the company is now asking health systems to trust AI safety claims that plaintiffs in court are actively disputing.
Ask SkimNews
